InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

- Current share price for AFP : $3.190

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$335 AFT CFO Malcolm Tubby to retire Simon Bosley CFO Designate 19 Nov 2025 7:32AM $2.710 $3.190 risen by 17.71%
$335 AFT to announce half year interim results Nov 20 24 Oct 2025 8:11AM $2.610 $3.190 risen by 22.22%
$335 September Quarter FY2026 Investor Update 25 Sep 2025 7:31AM $2.300 $3.190 risen by 38.70%
$335 Disclosure of Directors and Senior Managers Relevant Interes 1 Sep 2025 3:18PM $2.300 $3.190 risen by 38.70%
$335 Results of 2025 Annual Shareholder Meeting 4 Aug 2025 12:44PM $2.400 $3.190 risen by 32.92%
$335 AFT ASM Presentation 1 Aug 2025 7:30AM $2.400 $3.190 risen by 32.92%
$335 AFT ASM Chairs Speech 1 Aug 2025 7:30AM $2.400 $3.190 risen by 32.92%
$335 AFT ASM Release 1 Aug 2025 7:30AM $2.400 $3.190 risen by 32.92%
$335 Disclosure of Directors and Senior Managers Relevant Interes 4 Jul 2025 7:30AM $2.590 $3.190 risen by 23.17%
$335 June Quarter FY 2026 Investor Update 1 Jul 2025 7:31AM $2.430 $3.190 risen by 31.28%
$335 Disclosure of Directors and Senior Managers Relevant Interes 27 Jun 2025 7:31AM $2.270 $3.190 risen by 40.53%
$335 Notice of Annual Meeting of Shareholders 2025 27 Jun 2025 7:30AM $2.270 $3.190 risen by 40.53%
$335 Update - Dividend/Distribution - AFP 24 Jun 2025 3:04PM $2.270 $3.190 risen by 40.53%
$335 Update - Dividend/Distribution - AFP 24 Jun 2025 10:00AM $2.260 $3.190 risen by 41.15%
$335 AFT and Hikma extend US Maxigesic Cooperation 26 May 2025 10:06AM $2.450 $3.190 risen by 30.20%
$335 Dividend/Distribution - AFP 23 May 2025 3:10PM $2.450 $3.190 risen by 30.20%
$335 FY2025 Distribution Notice correction 22 May 2025 12:16PM $2.450 $3.190 risen by 30.20%
$335 FY2025 Distribution notice 22 May 2025 7:31AM $2.550 $3.190 risen by 25.10%
$335 FY2025 Presentation 22 May 2025 7:30AM $2.550 $3.190 risen by 25.10%
$335 FY2025 Annual Report 22 May 2025 7:30AM $2.550 $3.190 risen by 25.10%
$335 FY2025 Market Release 22 May 2025 7:30AM $2.550 $3.190 risen by 25.10%
$335 FY2025 App2 22 May 2025 7:30AM $2.550 $3.190 risen by 25.10%
$335 AFTto announce full year results on Thursday May 22 2025 1 May 2025 7:30AM $2.340 $3.190 risen by 36.32%
$335 March investor update 31 Mar 2025 8:09AM $2.300 $3.190 risen by 38.70%
$335 ASX small cap presentation 250326 26 Mar 2025 7:51AM $2.300 $3.190 risen by 38.70%

26 - 50 of 538 results

Page 2 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.